SVOBODA, Petr. The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury. Trials. 2009, 10:109.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.
Name in Czech The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.
Name (in English) The Brain Trial a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients With trumatic brain injury.
Authors SVOBODA, Petr.
Edition Trials, 2009.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30211 Orthopaedics
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords (in Czech) bradykini - antagonista - mozek - úraz
Keywords in English bradykinin - antagonist - brain - injury
Changed by Changed by: Pavla Hanková, učo 133528. Changed: 28/1/2010 14:40.
Abstract
The trial evaluated safety and effectiveness of the non-peptide bradykinin B2 antagonist Anatibant in the treatment of patients with traumatic brain injury.
Abstract (in English)
The trial evaluated safety and effectiveness of the non-peptide bradykinin B2 antagonist Anatibant in the treatment of patients with traumatic brain injury.
PrintDisplayed: 22/7/2024 20:34